ClinVar Miner

Submissions for variant NM_002691.4(POLD1):c.1481T>A (p.Ile494Asn)

dbSNP: rs1601217092
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001011807 SCV001172174 uncertain significance Hereditary cancer-predisposing syndrome 2019-09-04 criteria provided, single submitter clinical testing The p.I494N variant (also known as c.1481T>A), located in coding exon 11 of the POLD1 gene, results from a T to A substitution at nucleotide position 1481. The isoleucine at codon 494 is replaced by asparagine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GenomeConnect, ClinGen RCV001787122 SCV002029150 not provided not provided no assertion provided phenotyping only Variant interpreted as Uncertain significance and reported on 09-04-2019 by Lab or GTR ID 61756. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.